Mucor circinelloides induces platelet aggregation through integrin αIIbβ3 and FcγRIIA

Platelets

Volumn 30, Issue 2, 2019, Pages 256-263

  Ghuman, Harlene ^a   Shepherd Roberts, Alicia ^a   Watson, Stephanie ^a   Zuidscherwoude, Malou ^a,b   Watson, Steve P ^a,b   Voelz, Kerstin ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Fc RIIA; Mucor circinelloides; mucormycetes; mucormycosis; platelets; thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ALPHA2BETA3 INTEGRIN; CONCANAVALIN A; DASATINIB; EPTIFIBATIDE; FC RECEPTOR IIA; GLYCOPROTEIN; IMMUNOGLOBULIN G; INDOMETACIN; INTEGRIN; PADGEM PROTEIN; PROTEIN KINASE SYK; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOCYTE RECEPTOR; THROMBOXANE A2; UNCLASSIFIED DRUG; FC RECEPTOR;

ARTICLE; BACTERIAL SPORE; BLOOD ANALYSIS; BLOOD CLOTTING; BLOOD SMEAR; DEVELOPMENTAL STAGE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FUNGUS SPORE; IMPEDANCE; LIGHT TRANSMISSION AGGREGOMETRY; MUCOR CIRCINELLOIDES; MUCORMYCOSIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOCYTE RICH PLASMA; THROMBOSIS; GENETICS; HUMAN; IMMUNOLOGY; MUCOR; PATHOGENICITY;

HUMANS; MUCOR; PLATELET AGGREGATION; RECEPTORS, IGG; THROMBOSIS;

EID: 85041131467     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2017.1420152     Document Type: Article

References (33)

1. Chayakulkeeree M, Ghannoum MA, Perfect JR., Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006;25(4):215–229.
2. Greenberg RN, Scott LJ, Vaughn HH, Ribes, JA. zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis. 2004;17(6):517–525.
3. Spellberg B, Edwards J, Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005;18(3):556–569.
4. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, et alet alEpidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653.
5. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv113.
6. Perkhofer S, Kainzner B, Kehrel BE, Dierich MP, Nussbaumer W, Lass-Florl C. Potential antifungal effects of human platelets against zygomycetes in vitro. J Infect Dis. 2009;200(7):1176–1179.
7. Keane C, Petersen H, Reynolds K, Newman DK, Cox D, Jenkinson HF, Newman PJ, Kerrigan SW. Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii. Arterioscler Thromb Vasc Biol. 2010;30(12):2408–2415.
8. Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, Kerrigan SW, Watson SP. Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood. 2014;123(20):3166–3174.
9. Watson CN, Kerrigan SW, Cox D, Henderson IR, Watson SP, Arman M. Human platelet activation by Escherichia coli: roles for FcgammaRIIA and integrin alphaIIbbeta3. Platelets. 2016;27(6):535–40. doi: 10.3109/09537104.2016.1148129.
10. Li CH, Cervantes M, Springer DJ, Boekhout T, Ruiz-Vazquez RM, Torres-Martinez SR, Heitman J, Lee SC. Sporangiospore size dimorphism is linked to virulence of Mucor circinelloides. PLoS Pathog. 2011;7(6):e1002086.
11. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, et alet alFiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676–682.
12. Preibisch S, Amat F, Stamataki E, Sarov M, Singer RH, Myers E, Tomancak P. Efficient Bayesian-based multiview deconvolution. Nat Methods. 2014;11(6):645–648.
13. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost. 2011;9(6):1097–1107.
14. Qiao J, Al-Tamimi M, Baker RI, Andrews RK, Gardiner EE. The platelet Fc receptor, FcgammaRIIa. Immunol Rev. 2015;268(1):241–252.
15. Deppermann C, Kubes P. Platelets and infection. Semin Immunol. 2016;28(6):536–545.
16. Senis YA, Mazharian A, Mori J. Src family kinases: at the forefront of platelet activation. Blood. 2014;124(13):2013–2024.
17. Thornber K, McCarty OJ, Watson SP, Pears CJ. Distinct but critical roles for integrin alphaIIbbeta3 in platelet lamellipodia formation on fibrinogen, collagen-related peptide and thrombin. Febs J. 2006;273(22):5032–5043.
18. Wasiluk A, Kemona H, Mantur M, Polewko A, Ozimirski A, Milewski R. Expression of P-selectin (CD62P) on platelets after thrombin and ADP in hypotrophic and healthy, full-term newborns. J Matern Fetal Neonatal Med. 2013;26(13):1321–1324.
19. Paul BZ, Jin J, Kunapuli SP. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. J Biol Chem. 1999;274(41):29108–29114.
20. Woulfe D, Yang J, Brass L. ADP and platelets: the end of the beginning. J Clin Invest. 2001;107(12):1503–1505.
21. Petraitis V, Petraitiene R, Antachopoulos C, Hughes JE, Cotton MP, Kasai M, Harrington S, Gamaletsou MN, Bacher JD, Kontoyiannis DP, et alet alIncreased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism. Med Mycol. 2013;51(1):72–82.
22. Senet JM. Candida adherence phenomena, from commensalism to pathogenicity. Int Microbiol. 1998;1(2):117–122.
23. Kerrigan SW. The expanding field of platelet-bacterial interconnections. Platelets. 2015;26(4):293–301.
24. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006;4(6):445–457.
25. Pampolina C, McNicol A. Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. Thromb Haemost. 2005;93(5):932–939.
26. Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ. Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood. 2008;112(7):2780–2786.
27. Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ. Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood. 2013;121(10):1858–1867.
28. Perkhofer S, Kehrel BE, Dierich MP, Donnelly JP, Nussbaumer W, Hofmann J, Von Eiff C, Lass-Florl C. Human platelets attenuate Aspergillus species via granule-dependent mechanisms. J Infect Dis. 2008;198(8):1243–1246.
29. Whiteheart SW. Platelet granules: surprise packages. Blood. 2011;118(5):1190–1191.
30. Chang FY, Singh N, Gayowski T, Wagener MM, Mietzner SM, Stout JE, Marino IR. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation. 2000;69(1):70–75.
31. Bloxham CA, Carr S, Ryan DW, Kesteven PJ, Bexton RS, Griffiths ID, Richards J. Disseminated zygomycosis and systemic lupus erythematosus. Intensive Care Med. 1990;16(3):201–207.
32. Bartnickigarcia S, Reyes E. Chemistry of spore wall differentiation in Mucor Rouxii. Arch Biochem Biophys. 1964;108(1):125.
33. Bertling A, Niemann S, Uekotter A, Fegeler W, Lass-Florl C, Von Eiff C, Kehrel BE. Candida albicans and its metabolite gliotoxin inhibit platelet function via interaction with thiols. Thromb Haemost. 2010;104(2):270–278.